Recent News

• 06.12.2025 - Life at Nautilus interview with Lisen Wang – Senior Staff Engineer
• 06.10.2025 - Goldman Sachs 46th Annual Global Healthcare Conference
• 06.05.2025 - Proteoforms, metastasis, and cancer therapy responses – Applications of proteomics in cancer
• 05.29.2025 - Spatial Proteomics with Fiona Ginty Ph.D. – Translating Proteomics
• 05.27.2025 - Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
• 05.22.2025 - Proteomics and the food of the future
• 05.15.2025 - Proteoforms and EGFR signaling – Applications of proteomics in cancer
• 05.08.2025 - Life at Nautilus Interview with Denise Miller – Associate Director of Software Engineering
• 05.01.2025 - Unlocking the potential of plasma proteomics
• 04.29.2025 - Nautilus Q1 2025 Earnings Conference Call

Recent Filings

• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.12.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.02.2025 - 8-K Current report
• 04.29.2025 - ARS Annual Report to Security Holders
• 04.29.2025 - DEF 14A Other definitive proxy statements
• 04.29.2025 - 8-K Current report
• 04.29.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]